Nanexa AB (FRA:40M) Total Current Assets: €7.40 Mil (As of Mar. 2026)

What is Nanexa AB Total Current Assets?

Nanexa AB FRA:40M +2.49% 48 Total Current Assets is €7.40 Mil as of Mar. 2026. GuruFocus rates FRA:40M with a GF Score™ of 48/100 and a GF Value™ of €0.18 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Nanexa AB's total current assets for the quarter that ended in Mar. 2026 was €7.40 Mil.

Nanexa AB (FRA:40M) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Nanexa AB's Liquidation Value for the quarter that ended in Mar. 2026 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	6.779	-	3.674	+	0.75 * 0.616	+	0.5 * 0.002
=	3.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanexa AB Total Current Assets Related Terms

Nanexa AB Total Current Assets Historical Data

* Premium members only.

The historical data trend for Nanexa AB's Total Current Assets can be seen below:

Nanexa AB Total Current Assets Chart

Nanexa AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Current Assets

Get a 7-Day Free Trial

10.66

8.16

6.91

1.70

4.92

Nanexa AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Current Assets	Get a 7-Day Free Trial															5.17	4.26	2.90	4.92	7.40

48GF Score

Nanexa AB FRA:40M

Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Nanexa AB Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Nanexa AB's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	4.095	+	0.524	+	0	+	0.304
	=	4.92

Nanexa AB's Total Current Assets for the quarter that ended in Mar. 2026 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	6.779	+	0.616	+	0.002	+	0
	=	7.40

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →

What does a Total Current Assets of €7.40 Mil mean?

Nanexa AB (FRA:40M) has a Total Current Assets of €7.40 Mil as of Mar. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Nanexa AB and its competitors.

Is Nanexa AB's Total Current Assets too high?

Nanexa AB's current Total Current Assets is €7.40 Mil. Overall, Nanexa AB has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Nanexa AB's Total Current Assets compare to ZTS and UTHR?

Nanexa AB's Total Current Assets of €7.40 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Current Assets for a Drug Manufacturers company?

A good Total Current Assets depends on the Drug Manufacturers industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Current Assets mean?

A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Nanexa AB and its competitors. Nanexa AB's current Total Current Assets is €7.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Nanexa AB stock overvalued right now?

Based on GuruFocus' analysis, Nanexa AB (FRA:40M) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.18, compared to a current price of €0.31 — trading 71.4% above its estimated fair value. The current Total Current Assets is €7.40 Mil. Nanexa AB's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Current Assets calculated?

Total Current Assets is calculated from a company's financial statements. For Nanexa AB (FRA:40M), the current Total Current Assets is €7.40 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanexa AB (FRA:40M) Overvalued in 2026?

Based on GuruFocus' analysis, Nanexa AB stock appears to be overvalued. The current stock price of €0.31 is trading 71.4% above its estimated GF Value™ of €0.18. GuruFocus considers Nanexa AB to be Significantly Overvalued.

Key valuation signals for FRA:40M:

Total Current Assets: €7.40 Mil
GF Value™: €0.18 vs. price of €0.31 (71.4% above fair value)
GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the FRA:40M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanexa AB Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies OSTO:EQL OSTO:DICOT OSTO:ENZY OSTO:CINPHA OSTO:ORX OSTO:MOB OSTO:KLAR XSAT:ACUC OSTO:VIVE OSTO:NEWBRY XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges NANEXA:Sweden

Address Virdings Alle 32B, Uppsala, SWE, 75450

Website https://www.nanexa.com

Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its products and also has collaboration agreements with several pharma companies, among others AstraZeneca. Geographically, the company derives maximum revenue from Nordic countries, while it also has its presence in Europe (excluding the Nordic countries), North America, and Asia.

48GF Score

Get the complete analysis for FRA:40M

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.31

Price

€0.18

GF Value

View FRA:40M Analysis

See Total Current Assets data for all stocks →